Showing results (11-20 of 151) with videos related to
Sort By:
Pageof 16
Thrombosis and Haemostasis|March 23, 2019
Alcohol Consumption and Risk of First-Time Venous Thromboembolism in Men and WomenMagdalena Johansson, Lars Johansson, Maria Wennberg, et al.Thrombosis Journal|August 21, 2024
Cancer incidence and mortality after a first-ever venous thrombosis: a cohort study in northern SwedenLovisa Hägg, Felicia Ehrs, Marcus Lind, et al.Primary Care Diabetes|November 8, 2011
The relationship between the exposure time of insulin glargine and risk of breast and prostate cancer: an observational study of the time-dependent effects of antidiabetic treatments in patients with diabetesMarcus Lind, Martin Fahlén, Björn Eliasson, et al.Frontiers in Clinical Diabetes and Healthcare|January 3, 2025
Inhibition of leukotrienes and their potential role in type 1 diabetes pathogenesis: implications for montelukast as a therapeutic agent: a case reportPavel Fatulla, Ingela Ström, Christine Lingblom, et al.Journal of Diabetes Science and Technology|October 26, 2020
Evaluation of Reference Metrics for Continuous Glucose Monitoring in Persons Without Diabetes and PrediabetesSheyda Sofizadeh, Anders Pehrsson, Arndís F Ólafsdóttir, et al.Frontiers in Clinical Diabetes and Healthcare|May 1, 2025
Design and methods of a multicenter randomized clinical trial of effects of diabetes-educated psychologist on glucose management and diabetes distressJohanna Zeijlemaker, Therese Anderbro, Sofia Sterner Isaksson, et al.Diabetes Technology & Therapeutics|January 10, 2009
The effect of insulin lispro on glycemic control in a large patient cohortMarcus Lind, Martin Fahlén, Michael Happich, et al.Clinical Chemistry and Laboratory Medicine|June 12, 2016
High homocysteine and low folate plasma concentrations are associated with cardiovascular events but not bleeding during warfarin treatmentMarcus Lind, Jan-Håkan Jansson, Torbjörn K Nilsson, et al.BMJ Open|November 12, 2025
Design and methods of the Ixekizumab Diabetes Intervention Trial (I-DIT): protocol for a phase 2, randomised, multicentre, placebo-controlled, double-blind trial of anti-interleukin 17 as a treatment option for adults with new-onset type 1 diabetesShilan Seyed Ahmadi, Olle Korsgren, Per-Anders Jansson, et al.Acta Diabetologica|September 17, 2025
Retinopathy and nephropathy in type 1 diabetes: role of HbA1c and blood pressure variabilityPavel Fatulla, Johnny Ludvigsson, Henrik Imberg, et al.Pageof 16